Pharmaceutical Compositions Comprising Botulinum Neurotoxin

Patent No. EP2939688 (titled "Pharmaceutical Compositions Comprising Botulinum Neurotoxin") was filed by Ipsen Biopharm on Jul 6, 2005. The application was issued on Feb 20, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ALLERGANNov 20, 2019HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2939688

IPSEN BIOPHARM
Application Number
EP15000178A
Filing Date
Jul 6, 2005
Status
Opposition Rejected
Apr 21, 2023
Publication Date
Feb 20, 2019